Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Merck heart drug surprises with positive result; questions linger

      Merck heart drug surprises with positive result; questions linger

      Ruby Khatun Khatun28 Jun 2017 12:37 PM IST
      Merck & Co said on Tuesday its experimental cholesterol drug from a class with a history of consistent failure lowered deaths and heart attacks in...
      Health Startup Dozee CEO Mudit Dandwate forearm ripped off by crocodile

      Health Startup Dozee CEO Mudit Dandwate forearm ripped off by crocodile

      Ruby Khatun Khatun27 Jun 2017 4:07 PM IST
      Bengaluru: A bid to save his dogs that had strayed into a lake in neighbouring Ramanagar district cost a city-based entrepreneur looses his arm, as a...
      Pharma Doyen, Lupin founder passes away

      Pharma Doyen, Lupin founder passes away

      Ruby Khatun Khatun27 Jun 2017 3:03 PM IST
      Mumbai: Dr Desh Bandhu Gupta, Founder and Chairman of Lupin Limited (Lupin), passed away early this morning in Mumbai. He was 79 years old. He will be...
      Fraud trial for pharma bad boy Martin Shkreli begins

      Fraud trial for pharma bad boy Martin Shkreli begins

      Ruby Khatun Khatun27 Jun 2017 12:54 PM IST
      NEW YORK: Martin Shkreli, the former pharmaceutical executive dubbed "the most hated man in America" for his astronomical price hikes on an AIDS...
      Sun Pharma and NIV sign agreement to fight Zika, Chikungunya and Dengue

      Sun Pharma and NIV sign agreement to fight Zika, Chikungunya and Dengue

      Ruby Khatun Khatun27 Jun 2017 12:46 PM IST
      Mumbai, Pune & New Delhi: Sun Pharma and The National Institute of Virology (NIV), Pune, an institution of the Indian Council of Medical Research,...
      Takeda Pharmaceutical, Biological E in pact for vaccine development

      Takeda Pharmaceutical, Biological E in pact for vaccine development

      Ruby Khatun Khatun27 Jun 2017 9:51 AM IST
      Hyderabad: Takeda Pharmaceutical Company and Biological E Ltd (BE) have signed two licensing agreements for development and delivery of affordable...
      FDA approves first subcutaneous C1 Esterase Inhibitor to treat rare genetic disease

      FDA approves first subcutaneous C1 Esterase Inhibitor to treat rare genetic disease

      Ruby Khatun Khatun26 Jun 2017 9:16 AM IST
      The U.S. Food and Drug Administration approved Haegarda, the first C1 Esterase Inhibitor (Human) for subcutaneous (under the skin) administration to...
      FDA approves more convenient form of Roche blood cancer drug

      FDA approves more convenient form of Roche blood cancer drug

      Ruby Khatun Khatun25 Jun 2017 11:16 AM IST
      U.S. health regulators on Thursday approved a new formulation of Roche's big-selling cancer drug Rituxan for three common types of blood cancers that...
      Substandard: Nepal drugs watchdog asks Patanjali to recall six medicines

      Substandard: Nepal drugs watchdog asks Patanjali to recall six medicines

      Ruby Khatun Khatun25 Jun 2017 9:20 AM IST
      Kathmandu: Nepal's drugs watchdog has asked Ramdev's Patanjali Ayurveda to recall six Ayurvedic medicines after they were found to be of "substandard...
      US ruling threatens massive talc litigation against Johnson & Johnson

      US ruling threatens massive talc litigation against Johnson & Johnson

      Ruby Khatun Khatun25 Jun 2017 9:17 AM IST
      Johnson & Johnson is seizing upon a U.S. Supreme Court ruling from Monday limiting where injury lawsuits can be filed to fight off claims it...
      Novartis eye drug works with fewer injections than rival

      Novartis eye drug works with fewer injections than rival

      Ruby Khatun Khatun24 Jun 2017 12:03 PM IST
      ZURICH: A Novartis drug to treat a leading cause of vision loss in people over 65 does not need to be injected as frequently as a rival medicine from...
      Natco Pharma CEO Donates Rs 15 Crore to L V Prasad Eye Institute for children eye care

      Natco Pharma CEO Donates Rs 15 Crore to L V Prasad Eye Institute for children eye care

      Ruby Khatun Khatun24 Jun 2017 11:27 AM IST
      Hyderabad: Mr Rajeev Nannapaneni, Vice Chairman and CEO, Natco Pharma Limited, donated 1.5 lakh shares valued at Rs 15 crores to Hyderabad Eye...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok